NYLI Epoch International Choice Fund Inv (ICELX)
42.81
-0.04
(-0.09%)
USD |
May 16 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.54% | 254.96M | 2.93% | 60.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 13.21M | 3.66% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. Under normal circumstances the Fund will invest at least 80% of its assets in foreign equity securities which includes common stock depository receipts and securities convertible into common stock such as warrants rights convertible bonds debentures and convertible preferred stocks. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Growth |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
36
-1.284B
Peer Group Low
1.195B
Peer Group High
1 Year
% Rank:
26
13.21M
-16.58B
Peer Group Low
5.795B
Peer Group High
3 Months
% Rank:
58
-4.223B
Peer Group Low
2.020B
Peer Group High
3 Years
% Rank:
44
-49.92B
Peer Group Low
17.01B
Peer Group High
6 Months
% Rank:
44
-9.537B
Peer Group Low
1.863B
Peer Group High
5 Years
% Rank:
65
-75.56B
Peer Group Low
30.86B
Peer Group High
YTD
% Rank:
54
-5.954B
Peer Group Low
1.986B
Peer Group High
10 Years
% Rank:
89
-80.09B
Peer Group Low
36.64B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 18, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.24% |
| Stock | 97.81% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 1.95% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Keyence Corp | 4.61% | 441.23 | 0.30% |
| AstraZeneca PLC | 4.43% | 68.81 | 1.25% |
| NN Group NV | 4.27% | 61.50 | 0.00% |
| Nordea Bank Abp | 4.19% | 14.02 | 0.00% |
| Lloyds Banking Group PLC | 4.15% | 1.01 | 0.00% |
| Unilever PLC | 3.86% | 60.26 | 1.76% |
| Severn Trent PLC | 3.76% | 32.39 | 0.00% |
| Vonovia SE | 3.43% | 33.75 | 7.48% |
| Deutsche Post AG | 3.39% | 43.25 | -0.94% |
| AXA SA | 3.35% | 46.83 | 4.04% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 0.63% |
| Administration Fee | -- |
| Maximum Front Load | 5.00% |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 2500.00 None |
| Minimum Subsequent Investment | 50.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. Under normal circumstances the Fund will invest at least 80% of its assets in foreign equity securities which includes common stock depository receipts and securities convertible into common stock such as warrants rights convertible bonds debentures and convertible preferred stocks. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Growth |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-16-25) | 0.87% |
| 30-Day SEC Yield (6-30-21) | 0.44% |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 21.06 |
| Weighted Average Price to Sales Ratio | 3.664 |
| Weighted Average Price to Book Ratio | 4.243 |
| Weighted Median ROE | 19.17% |
| Weighted Median ROA | 7.02% |
| ROI (TTM) | 12.45% |
| Return on Investment (TTM) | 12.45% |
| Earning Yield | 0.0635 |
| LT Debt / Shareholders Equity | 0.9124 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 12.85% |
| EPS Growth (3Y) | 15.44% |
| EPS Growth (5Y) | 11.68% |
| Sales Growth (1Y) | 6.81% |
| Sales Growth (3Y) | 9.11% |
| Sales Growth (5Y) | 7.96% |
| Sales per Share Growth (1Y) | 7.92% |
| Sales per Share Growth (3Y) | 9.82% |
| Operating Cash Flow - Growth Ratge (3Y) | 10.22% |
As of March 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:ICELX", "name") |
| Broad Asset Class: =YCI("M:ICELX", "broad_asset_class") |
| Broad Category: =YCI("M:ICELX", "broad_category_group") |
| Prospectus Objective: =YCI("M:ICELX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |